- authorisedTherapeutic use (Phase IV)
Evaluation of clinical impact of the type of cardioplegia used in the patient undergoing major cardiac surgery with extracorporeal circulation. CARDIO-HEART clinical trial.
This study is looking at different ways to protect the heart during major heart surgery. It compares two methods of 'cardioplegia' (heart protection solution) to see which one leads to better outcomes for patients, such as fewer problems after surgery.
Spain - not yet recruitingNA
The Effects of a 6-week Pre-operative Administration of a Microbiome Modulator "WellBiome" Versus Placebo on Cardiac Surgical Outcomes and NHS Cost Savings.
This study looks at whether a special fibre and mineral supplement called WellBiome, taken for 6-8 weeks before heart surgery, can help patients recover faster. Researchers want to see if it reduces time in intensive care, shortens hospital stays, and lowers complications by improving gut health.
United Kingdom